- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/145 - Orthomyxoviridae, e.g. influenza virus
Patent holdings for IPC class A61K 39/145
Total number of patents in this class: 2689
10-year publication summary
|
173
|
206
|
208
|
181
|
211
|
204
|
172
|
175
|
183
|
64
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1701 |
80 |
| Seqirus UK Limited | 402 |
51 |
| Wisconsin Alumni Research Foundation | 3774 |
48 |
| Icahn School of Medicine at Mount Sinai | 859 |
44 |
| Medicago Inc. | 203 |
44 |
| Curevac SE | 235 |
44 |
| Novartis AG | 11238 |
42 |
| University of Georgia Research Foundation, Inc. | 972 |
34 |
| Janssen Vaccines & Prevention B.V. | 337 |
32 |
| The Trustees of the University of Pennsylvania | 4122 |
27 |
| Boehringer Ingelheim Animal Health USA Inc. | 507 |
27 |
| FluGen, Inc. | 37 |
25 |
| Modernatx, Inc. | 1181 |
25 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 2912 |
25 |
| Sanofi Pasteur Inc. | 246 |
24 |
| University of Rochester | 1243 |
22 |
| Intervet Inc. | 848 |
21 |
| Intervet International B.V. | 1235 |
21 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
20 |
| Academia Sinica | 888 |
19 |
| Other owners | 2014 |